Switch to:
More From Other Websites
Agenus Announces Commencement of Phase 1/2 Clinical Trial of anti-OX40 Checkpoint Antibody... Dec 01 2016
Agenus' INCAGN1876 in Phase I/II Study for Solid Tumors Dec 01 2016
Agenus Announces Commencement of Phase 1/2 Clinical Trial of anti-OX40 Checkpoint Antibody... Nov 30 2016
AGENUS INC Financials Nov 17 2016
ETFs with exposure to Agenus, Inc. : November 16, 2016 Nov 16 2016
Agenus to Present at the Jefferies 2016 London Healthcare Conference Nov 14 2016
AGENUS INC Files SEC form 10-Q, Quarterly Report Nov 09 2016
ETF’s with exposure to Agenus, Inc. : October 31, 2016 Oct 31 2016
Agenus, Inc. :AGEN-US: Earnings Analysis: Q3, 2016 By the Numbers : October 28, 2016 Oct 28 2016
Agenus (AGEN) Reports Wider-than-Expected Loss in Q3 Oct 28 2016
Agenus downgraded by H.C. Wainwright Oct 28 2016
Agenus 3Q Loss $41M, or 47 Cents a Share (AGEN) Oct 28 2016
Agenus (AGEN) Reports Narrower-than-Expected Q3 Loss Oct 27 2016
Agenus reports 3Q loss Oct 27 2016
Agenus reports 3Q loss Oct 27 2016
Agenus Reports Third Quarter Financial Results and Recent Highlights Oct 27 2016
AGENUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Oct 27 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK